{
    "title": "Relief Therapeutics sees 60-70% chance of COVID-19 drug approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8606673/Relief-Therapeutics-sees-60-70-chance-COVID-19-drug-approval.html",
    "date": "2020-08-08",
    "keywords": [
        "drug",
        "covid19",
        "approval",
        "trial",
        "standpoint",
        "selvaraju",
        "friday",
        "year",
        "chairman",
        "matter",
        "group",
        "partner",
        "neurorx",
        "phase",
        "respiratory",
        "disease",
        "coronavirus",
        "ingredient",
        "aviptadil",
        "lot",
        "safety",
        "raghuram",
        "newspaper",
        "market",
        "interview",
        "efficacy",
        "probability",
        "moment",
        "food",
        "administration",
        "expedient",
        "manner",
        "relief",
        "polypeptide",
        "replication",
        "sarscov2",
        "virus",
        "lung",
        "anticipation",
        "progress",
        "company",
        "michael",
        "andrew"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}